209 related articles for article (PubMed ID: 22486212)
1. Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity.
Ismail SA; Mohamed SA
Br J Dermatol; 2012 Aug; 167(2):436-9. PubMed ID: 22486212
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of novel adipocytokines in patients with colorectal cancer.
Fazeli MS; Dashti H; Akbarzadeh S; Assadi M; Aminian A; Keramati MR; Nabipour I
Cytokine; 2013 Apr; 62(1):81-5. PubMed ID: 23474107
[TBL] [Abstract][Full Text] [Related]
3. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
[TBL] [Abstract][Full Text] [Related]
4. Omentin-1 plasma levels and omentin-1 expression are decreased in psoriatic lesions of psoriasis patients.
Zhang C; Zhu KJ; Liu JL; Xu GX; Liu W; Jiang FX; Zheng HF; Quan C
Arch Dermatol Res; 2015 Jul; 307(5):455-9. PubMed ID: 25690163
[TBL] [Abstract][Full Text] [Related]
5. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues.
Nway NC; Sitticharoon C; Chatree S; Maikaew P
Obes Res Clin Pract; 2016; 10(3):256-63. PubMed ID: 26067914
[TBL] [Abstract][Full Text] [Related]
6. Correlation of metabolic syndrome with serum omentin-1 and visfatin levels and disease severity in psoriasis and psoriatic arthritis.
Dağdelen D; Karadag AS; Kasapoğlu E; Wang JV; Erman H
Dermatol Ther; 2020 Nov; 33(6):e14378. PubMed ID: 33029930
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis.
Takahashi H; Tsuji H; Honma M; Ishida-Yamamoto A; Iizuka H
Arch Dermatol Res; 2013 Mar; 305(2):113-6. PubMed ID: 23291856
[TBL] [Abstract][Full Text] [Related]
8. Omentin serum levels and omentin gene Val109Asp polymorphism in patients with psoriasis.
Turan H; Yaykasli KO; Soguktas H; Yaykasli E; Aliagaoglu C; Erdem T; Karkucak M; Kaya E; Ucgun T; Bahadir A
Int J Dermatol; 2014 May; 53(5):601-5. PubMed ID: 24321036
[TBL] [Abstract][Full Text] [Related]
9. Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
Gerdes S; Osadtschy S; Rostami-Yazdi M; Buhles N; Weichenthal M; Mrowietz U
Exp Dermatol; 2012 Jan; 21(1):43-7. PubMed ID: 22151390
[TBL] [Abstract][Full Text] [Related]
10. Serum Levels of Visfatin, Omentin and Irisin in Patients with End-Stage Lung Disease Before and After Lung Transplantation.
Ochman M; Maruszewski M; Wojarski J; Żegleń S; Karolak W; Stanjek-Cichoracka A; Przybyłowski P; Zembala M; Kukla M
Ann Transplant; 2017 Dec; 22():761-768. PubMed ID: 29277835
[TBL] [Abstract][Full Text] [Related]
11. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome.
Jialal I; Devaraj S; Kaur H; Adams-Huet B; Bremer AA
J Clin Endocrinol Metab; 2013 Mar; 98(3):E514-7. PubMed ID: 23303213
[TBL] [Abstract][Full Text] [Related]
12. Visfatin--a proinflammatory adipokine-in gallstone disease.
Wang SN; Yeh YT; Wang ST; Chuang SC; Wang CL; Yu ML; Lee KT
Am J Surg; 2010 Apr; 199(4):459-65. PubMed ID: 19427623
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum adipokines (omentin-1 and visfatin) in coronary artery disease at a North Indian hospital.
Ali S; Alam R; Ahmad MK; Ahmad M; Ahsan H; Khan MM; Khan S
Endocr Regul; 2023 Jan; 57(1):262-268. PubMed ID: 38127689
[No Abstract] [Full Text] [Related]
14. Visfatin, low-grade inflammation and body mass index (BMI).
Samara A; Pfister M; Marie B; Visvikis-Siest S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):568-74. PubMed ID: 18248642
[TBL] [Abstract][Full Text] [Related]
15. Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM.
Souvannavong-Vilivong X; Sitticharoon C; Klinjampa R; Keadkraichaiwat I; Sripong C; Chatree S; Sririwichitchai R; Lertbunnaphong T
Acta Diabetol; 2019 Oct; 56(10):1121-1131. PubMed ID: 31076892
[TBL] [Abstract][Full Text] [Related]
16. Serum Visfatin, Adiponectin, and Tumor Necrosis Factor Alpha (TNF-α) Levels in Patients with Psoriasis and their Correlation with Disease Severity.
Sereflican B; Goksugur N; Bugdayci G; Polat M; Haydar Parlak A
Acta Dermatovenerol Croat; 2016 Apr; 24(1):13-9. PubMed ID: 27149125
[TBL] [Abstract][Full Text] [Related]
17. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
[TBL] [Abstract][Full Text] [Related]
18. Serum Visfatin, Fetuin-A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease Severity.
Okan G; Baki AM; Yorulmaz E; Doğru-Abbasoğlu S; Vural P
J Clin Lab Anal; 2016 Jul; 30(4):284-9. PubMed ID: 25867925
[TBL] [Abstract][Full Text] [Related]
19. Body fat distribution has no effect on serum visfatin levels in healthy female subjects.
Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S
Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351
[TBL] [Abstract][Full Text] [Related]
20. The correlation between insulin-like growth factor 1 (IGF-1) and novel adipocytokines in postmenopausal women: A population-based study.
Darabi H; Ostovar A; Raeisi A; Kalantarhormozi MR; Assadi M; Akbarzadeh S; Momeni S; Dobaradaran S; Vahdat K; Nabipour I
Endocr Res; 2017 Aug; 42(3):191-197. PubMed ID: 28287842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
